Neuberger Berman Group LLC Bristol Myers Squibb CO Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 556,975 shares of BMY stock, worth $23.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
556,975
Holding current value
$23.1 Million
% of portfolio
0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$47.98 - $54.4 $26.7 Million - $30.3 Million
556,975 New
556,975 $30.2 Million
Q4 2023

Feb 09, 2024
SELL
$48.48 - $57.85 $118 Million - $141 Million
-2,438,865 Reduced 44.74%
3,012,431 $155 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $2.87 Million - $3.21 Million
-49,643 Reduced 0.9%
5,451,296 $316 Million
Q2 2023

Aug 11, 2023
SELL
$63.71 - $70.74 $24.6 Million - $27.3 Million
-385,385 Reduced 6.55%
5,500,939 $352 Million
Q1 2023

May 12, 2023
BUY
$65.71 - $74.53 $7.77 Million - $8.82 Million
118,297 Added 2.05%
5,886,324 $408 Million
Q4 2022

Feb 13, 2023
BUY
$68.48 - $81.09 $86.4 Million - $102 Million
1,261,972 Added 28.01%
5,768,027 $415 Million
Q3 2022

Nov 15, 2022
SELL
$0.13 - $76.84 $42,821 - $25.3 Million
-329,397 Reduced 6.81%
4,506,055 $321 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $76.5 Million - $84.3 Million
1,053,951 Added 27.87%
4,835,452 $372 Million
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $47.4 Million - $56.9 Million
771,582 Added 25.63%
3,781,501 $274 Million
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $42.4 Million - $49.4 Million
-790,653 Reduced 20.8%
3,009,919 $186 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $641,698 - $751,666
-10,845 Reduced 0.28%
3,800,572 $224 Million
Q2 2021

Aug 13, 2021
BUY
$61.91 - $67.42 $90.5 Million - $98.6 Million
1,462,381 Added 62.25%
3,811,417 $253 Million
Q1 2021

May 13, 2021
SELL
$59.34 - $66.74 $33.7 Million - $37.9 Million
-567,808 Reduced 19.47%
2,349,036 $148 Million
Q4 2020

Feb 10, 2021
BUY
$57.74 - $65.43 $5.54 Million - $6.28 Million
95,925 Added 3.4%
2,916,844 $181 Million
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $26.6 Million - $29.4 Million
-462,545 Reduced 14.09%
2,820,919 $170 Million
Q2 2020

Aug 13, 2020
SELL
$54.82 - $64.09 $5.56 Million - $6.5 Million
-101,458 Reduced 3.0%
3,283,464 $193 Million
Q1 2020

May 14, 2020
SELL
$46.4 - $67.43 $3.54 Million - $5.15 Million
-76,354 Reduced 2.21%
3,384,922 $189 Million
Q4 2019

Feb 12, 2020
BUY
$49.21 - $64.19 $54.3 Million - $70.8 Million
1,103,467 Added 46.8%
3,461,276 $222 Million
Q3 2019

Nov 13, 2019
SELL
$42.77 - $50.71 $13.5 Million - $16 Million
-315,508 Reduced 11.8%
2,357,809 $120 Million
Q2 2019

Aug 13, 2019
SELL
$44.62 - $49.34 $1.94 Million - $2.14 Million
-43,435 Reduced 1.6%
2,673,317 $121 Million
Q1 2019

May 13, 2019
BUY
$45.12 - $53.8 $27.4 Million - $32.7 Million
607,233 Added 28.79%
2,716,752 $130 Million
Q4 2018

Feb 12, 2019
BUY
$48.76 - $63.23 $16.9 Million - $22 Million
347,234 Added 19.7%
2,109,519 $110 Million
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $39.5 Million - $44.6 Million
-715,856 Reduced 28.89%
1,762,285 $109 Million
Q2 2018

Aug 13, 2018
SELL
$50.53 - $62.98 $30.7 Million - $38.2 Million
-607,078 Reduced 19.68%
2,478,141 $137 Million
Q1 2018

May 08, 2018
SELL
$59.92 - $68.98 $5.27 Million - $6.06 Million
-87,873 Reduced 2.77%
3,085,219 $195 Million
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $19.5 Million - $21.3 Million
325,704 Added 11.44%
3,173,092 $194 Million
Q3 2017

Nov 15, 2017
BUY
$55.23 - $63.74 $157 Million - $181 Million
2,847,388
2,847,388 $181 Million

Others Institutions Holding BMY

# of Institutions
2,554
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email